Company news
Forte Biosciences, Inc. news in 2020
Forte Biosciences, Inc.'s news releases, calls and decks from 2020, newest first.
Forte Biosciences, Inc. Announces Third Quarter 2020 Results and Provides General Business Update
November 8, 2020
Forte Biosciences, Inc. to Announce Third Quarter 2020 Results on November 9
November 1, 2020
Forte Biosciences Announces Closing of $46.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 1, 2020
Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock
October 28, 2020
Forte Biosciences Announces Proposed Public Offering of Common Stock
October 27, 2020
Forte Biosciences, Inc. Announces the FDA Has Granted Fast Track Designation to FB-401 for the Treatment of Atopic Dermatitis
October 25, 2020
Forte Biosciences, Inc. Announces First Patient Dosed in the Clinical Trial of FB-401 for the Treatment of Children and Adults With Atopic Dermatitis
September 28, 2020
Forte Biosciences, Inc. Announces Full Publication of Phase 1/2 Data in Science Translational Medicine
September 8, 2020
Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
August 9, 2020
Forte Biosciences, Inc. to Announce Second Quarter 2020 Results on August 10
August 2, 2020
Forte Biosciences, Inc. Announces Issuance of New U.S. Patent
June 17, 2020